Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrations

Fig. 3

Overexpression of EHD1 confers resistance to CDDP in NSCLC cells. a Western blotting analysis to confirm the overexpression of EHD1. GAPDH was used as a control to verify the equal loading of protein. Relative protein levels of EHD1 were determined. b Inhibitory effect of CDDP was measured in NSCLC cells using the CCK-8 assay at 24Ā h. c The IC50 values for CDDP were determined in NSCLC cells at 24Ā h. d Inhibitory effect of CDDP was measured at 48Ā h. e The IC50 values for CDDP were determined at 48Ā h. f Annexin-V-FITC/PI staining was analysed by flow cytometry in NSCLC cells after treatment with CDDP for 24Ā h. g The histogram demonstrates the percentage of early apoptotic NSCLC cells in response to CDDP concentrations of 0, 2.5, 5 and 10Ā Ī¼M

Back to article page